Drug Response Dx is based in Hennigsdorf, Germany and was founded in February 2012 by Dr. Zoltán Konthur, Dr. Jörg-M. Hollidt, Dr. Karl Skriner and Dr. Joachim Rautter. The biomarker set is prevalidated; the biochemicals and test samples are present. The proof of concept in serums from RA patients is established.
Funding Rounds (1) - undisclosedUpdate
Current Team (4)Update
|Jan 9, 2013||FinSMEs - Drug Response Dx raises 0 in venture round|